- Home
- VERA vs PINC Comparison
VERA vs PINC Comparison
Compare VERA & PINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERA
- PINC
- Stock Information
- Founded
- VERA 2016
- PINC 2013
- Country
- VERA United States
- PINC United States
- Employees
- VERA N/A
- PINC N/A
- Industry
- VERA Biotechnology: Pharmaceutical Preparations
- PINC Other Consumer Services
- Sector
- VERA Health Care
- PINC Consumer Discretionary
- Exchange
- VERA Nasdaq
- PINC Nasdaq
- Market Cap
- VERA 2.0B
- PINC 1.9B
- IPO Year
- VERA 2021
- PINC 2013
- Fundamental
- Price
- VERA $23.20
- PINC $21.05
- Analyst Decision
- VERA Buy
- PINC Hold
- Analyst Count
- VERA 8
- PINC 6
- Target Price
- VERA $64.63
- PINC $22.20
- AVG Volume (30 Days)
- VERA 1.3M
- PINC 2.3M
- Earning Date
- VERA 08-07-2025
- PINC 08-19-2025
- Dividend Yield
- VERA N/A
- PINC 3.99%
- EPS Growth
- VERA N/A
- PINC N/A
- EPS
- VERA N/A
- PINC 0.63
- Revenue
- VERA N/A
- PINC $1,260,388,000.00
- Revenue This Year
- VERA N/A
- PINC N/A
- Revenue Next Year
- VERA N/A
- PINC N/A
- P/E Ratio
- VERA N/A
- PINC $33.25
- Revenue Growth
- VERA N/A
- PINC 7.16
- 52 Week Low
- VERA $18.53
- PINC $17.23
- 52 Week High
- VERA $51.61
- PINC $23.56
- Technical
- Relative Strength Index (RSI)
- VERA 49.75
- PINC 34.69
- Support Level
- VERA $22.57
- PINC $21.00
- Resistance Level
- VERA $24.58
- PINC $21.47
- Average True Range (ATR)
- VERA 1.13
- PINC 0.37
- MACD
- VERA 0.06
- PINC -0.08
- Stochastic Oscillator
- VERA 38.05
- PINC 17.41
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.